TORONTO, April 25, 2013 /CNW/ - The Medipattern Corporation ("Medipattern" or the "Company") (TSX-V: MKI.V), announced today that it has failed to reach a negotiated settlement with its secured creditors as earlier disclosed in a press release of the Company on March 13, 2013. The secured creditors have filed an application for appointment of an interim receiver pursuant to Section 47 of the Bankruptcy and Insolvency Act (Canada). The Company expects that this application will be approved today.
About the Medipattern Corporation:
Medipattern® is an award-winning leader in the development and commercialization of healthcare solutions that positively impact people's lives through the prevention of disease and analysis of medical images and data. Medipattern's Knowledge-based Informatics (MKI) platform enables delivery of these streamlined solutions. Medipattern mHealth uses patented prevention technologies to engage, coach and monitor people in achieving their personalized goals. Medipattern iaHealth uses patented pattern recognition technology to analyze medical data to aid medical practitioners in the assessment of disease and critical anatomy. For more information, please visit the Company's website: www.medipattern.com.
Medipattern® is registered trademarks of The Medipattern Corporation. Visualize:Vascular™ is a registered trademark of Medipattern.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
SOURCE: The Medipattern Corporation
For further information:
Jeff Collins, CEO
The Medipattern Corporation
(416) 744-0009 ext. 224